Defining patient centricity with patients for patients and caregivers: A collaborative endeavour

BMJ Innovations

Volumn 3, Issue 2, 2017, Pages 76-83

  Yeoman, Guy ^a   Furlong, Patricia ^b   Seres, Michael ^b   Binder, Helena ^c   Chung, Helena ^a   Garzya, Vincenzo ^a   Jones, Rachel R M ^a  

^a ASTRAZENECA   (United Kingdom)

^b 11Health ^*  (United Kingdom)

^c Corvista ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAREGIVER SUPPORT; FEEDBACK SYSTEM; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; INTERVIEW; MEDICAL EDUCATION; MEDICAL INFORMATION; ORGANIZATIONAL EFFICIENCY; PATIENT CARE; PATIENT CARE PLANNING; PATIENT COMFORT; PATIENT DECISION MAKING; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 85018408217     PISSN: 20558074     EISSN: 2055642X     Source Type: Journal    
DOI: 10.1136/bmjinnov-2016-000157     Document Type: Article

References (26)

1. Rago L, Santoso B. Drug regulation: history, present and future. In: Drug benefits and risks: international textbook of clinical pharmacology. 2nd edn. van Boxtel CJ, Santoso B, Edwards IR, eds. IOS Press and Uppsala Monitoring Centre, 2008.
2. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use 2015. http://www.ich.org/home (accessed Sep 2016).
3. Health Insurance Portability and Accountability. Standards for privacy of individually identifiable health information DHHS [45 CFR Parts 160, 162 & 164 (HIPAA)]. 2016 http://www.hhs.gov/hipaa/for-professionals/privacy/(accessed Sep 2016).
4. European Medicines Agency. The patient’s voice in the evaluation of medicines. How patients can contribute to the assessment of benefit and risk. 18th October 2013. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/10/WC500153276.pdf (accessed Jan 2017).
5. Patient and Public Involvement In Research. HealthTalk.Org 2016. http://www.healthtalk.org/peoples-experiences/improving-health-care/patient-and-public-involvement-research/what-patient-and-public-involvement-and-why-it-important (accessed Sep 2016).
6. Global Genes. Uniting patients and caregivers, researchers, industry and government regulators at the table. A white paper expanding the panel discussion at the Global Genes Third Annual RARE patient’s advocacy summit. March 2015. https://globalgenes.org/wp-content/uploads/2015/03/Drug-Development-White-Paper-2015-FINAL.pdf (accessed Sep 2016).
7. Schaeffer S, McAllister E, Usdin S. Back to school: changing the subject. BioCentury 7th September 2015. http://www.biocentury.com/Data/StaticContent/ContentFiles/090715_Cover_BTS.pdf (accessed Jan 2017).
8. Hoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines: a call for action. Ther Innov Reg Sci 2015;49:929–39.
9. Brown MT, Bussell JK. Medication adherence: WHO cares. Mayo Clin Proc 2011;86:304–14.
10. Stevenson-Grund A. Listen to reason: patient reasons for medication noncompliance. Orbis Biosciences March 13th, 2015. http://www.orbisbio.com/blog/listen-to-reason-patientreasons-for-medication-noncompliance (accessed Jan 2017).
11. Robbins DA, Curro FA, Fox CH. Defining patient-centricity: opportunities, challenges, and implications for clinical care and research. Ther Innov Reg Sci 2013;47:349–55.
12. Ernst and Young. Progressions: health care everywhere. Global Life Sciences Report 2012 http://www.ey.com/GL/en/Industries/Life-Sciences/Progressions-2012—Health-care-everywhere—Overview (accessed Sep 2016).
13. Food and Drug Administration. Patient-Focused Drug Development: Disease Area Meetings Planned for Fiscal Years 2013-2017. 2015. http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm347317.htm (accessed Sep 2016).
14. Food and Drug Administration. FDAVoice. FDA Announces First-ever Patient Engagement Advisory Committee. September 18, 2015. 2015. http://blogs.fda.gov/fdavoice/index.php/2015/09/fda-announces-first-ever-patient-engagement-advisorycommittee/(accessed 5 Apr 2016).
15. Food and Drug Administration. Externally-Led Patient-Focused Drug Development Meetings. A Notice by the Food and Drug Administration. 28 December 2015. 2015c. https://www.federalregister.gov/articles/2015/12/28/2015-32476/externally-led-patient-focused-drug-development-meetings (accessed Sep 2016).
16. European Medicines Agency. Press Release, 9 December 2015. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/12/WC500198366.pdf (accessed Sep 2016).
17. European Medicines Agency. News Release, 21 September 2015. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/09/news_detail_002394. jsp&mid=WC0b01ac058004d5c1 (accessed Sep 2016).
18. European Union Medicines Agencies Network Strategy to 2020. Working together to improve health. 17 December 2015 EMA/MB/151414/2015. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/12/WC500199060.pdf (accessed Sep 2016).
19. Muhlbacher AC. Patient-centric HTA: different strokes for different folks. Expert Rev Pharmacoecon Outcomes Res 2015;15:591–97.
20. Perfetto EM, Burke L, Oehrlein EM, et al. Patient-focused drug development: a new direction for collaboration. Med Care 2015;53:9–17.
21. Vaida B. Patient-centred research outcomes: early evidence from the field. Health Aff 2016;35:4595–602.
22. Furlong P, Bridges JFP, Charnas L, et al. How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration. Orphanet J Rare Dis 2015;10:82
23. Boutin M, Dewulf L, Hoos A, et al. Culture and process change as a priority for patient engagement in medicines development. Ther Innov Reg Sci 2017;51:29–38.
24. Department of Health. Liberating the NHS; no decision about me, without me. 20th July 2012. Available at: https://consultations.dh.gov.uk/choice/choice-future-proposals/supporting_documents/Choice%20consultation%20%20No%20decison%20about%20me%20without%20me.pdf (accessed Jan 2017).
25. IMS Consulting Group. The idea of Patient Centricity is becoming a significant strategic focus across all healthcare stakeholders. But what does this term really mean? What does success look like? And are life science companies succeeding? http://www.imshealth.com:90/files/web/Global/Services/Strategy%20&%20Management%20Consulting/Consulting%20Group%20TL/IMS_Patient_Centricity.pdf (accessed Jan 2017).
26. National Health Council. The patient voice in value: The National Health Council Patient-centered value model rubric. March 2016. http://www.nationalhealthcouncil.org/sites/default/files/Value-Rubric.pdf (accessed Jan 2017).